Use of Intravenous Gadolinium-Based Contrast Media in Patients With Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation
Jeffrey C. Weinreb, Roger A. Rodby, Jerry Yee, Carolyn L. Wang, Derek M. Fine, Robert J. McDonald, Mark A. Perazella, Jonathan R. Dillman, Matthew S. Davenport
Abstract
should be balanced against and may outweigh the risk of NSF. Dialysis initiation or alteration is likely unnecessary based on group II or group III GBCM administration.
Topics & Concepts
Consensus conferenceMedicineIntravenous contrastFoundation (evidence)Kidney diseaseGadoliniumDiseaseContrast (vision)KidneyRadiologyIntensive care medicineComputed tomographyPathologyInternal medicinePolitical scienceComputer scienceArtificial intelligenceLawMaterials scienceMetallurgyLanthanide and Transition Metal ComplexesAcute Kidney Injury ResearchAdvanced MRI Techniques and Applications